CoChat
Sign Up
Cited by 405Health disparities and outcomesSex and Gender in HealthcareRace, Genetics, and Society

The DOI matches its Crossref record; 444 of the 454 references it cites were found in a registry or an index.

Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

Open access
Golden, Sherita Hill, Brown, Arleen, Cauley, Jane A., Chin, Marshall H., Gary-Webb, Tiffany L., Kim, Catherine, Sosa, Julie Ann, Sumner, Anne E., Anton, Blair·2012·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2012-2043PMC PMC3431576
Open this paper in CoChat — free accountOpen PDF

Abstract

OBJECTIVE: The aim was to provide a scholarly review of the published literature on biological, clinical, and nonclinical contributors to race/ethnic and sex disparities in endocrine disorders and to identify current gaps in knowledge as a focus for future research needs. PARTICIPANTS IN DEVELOPMENT OF SCIENTIFIC STATEMENT: The Endocrine Society's Scientific Statement Task Force (SSTF) selected the leader of the statement development group (S.H.G.). She selected an eight-member writing group with expertise in endocrinology and health disparities, which was approved by the Society. All discussions regarding the scientific statement content occurred via teleconference or written correspondence. No funding was provided to any expert or peer reviewer, and all participants volunteered their time to prepare this Scientific Statement. EVIDENCE: The primary sources of data on global disease prevalence are from the World Health Organization. A comprehensive literature search of PubMed identified U.S. population-based studies. Search strategies combining Medical Subject Headings terms and keyword terms and phrases defined two concepts: 1) racial, ethnic, and sex differences including specific populations; and 2) the specific endocrine disorder or condition. The search identified systematic reviews, meta-analyses, large cohort and population-based studies, and original studies focusing on the prevalence and determinants of disparities in endocrine disorders. consensus process: The writing group focused on population differences in the highly prevalent endocrine diseases of type 2 diabetes mellitus and related conditions (prediabetes and diabetic complications), gestational diabetes, metabolic syndrome with a focus on obesity and dyslipidemia, thyroid disorders, osteoporosis, and vitamin D deficiency. Authors reviewed and synthesized evidence in their areas of expertise. The final statement incorporated responses to several levels of review: 1) comments of the SSTF and the Advocacy and Public Outreach Core Committee; and 2) suggestions offered by the Council and members of The Endocrine Society. CONCLUSIONS: Several themes emerged in the statement, including a need for basic science, population-based, translational and health services studies to explore underlying mechanisms contributing to endocrine health disparities. Compared to non-Hispanic whites, non-Hispanic blacks have worse outcomes and higher mortality from certain disorders despite having a lower (e.g. macrovascular complications of diabetes mellitus and osteoporotic fractures) or similar (e.g. thyroid cancer) incidence of these disorders. Obesity is an important contributor to diabetes risk in minority populations and to sex disparities in thyroid cancer, suggesting that population interventions targeting weight loss may favorably impact a number of endocrine disorders. There are important implications regarding the definition of obesity in different race/ethnic groups, including potential underestimation of disease risk in Asian-Americans and overestimation in non-Hispanic black women. Ethnic-specific cut-points for central obesity should be determined so that clinicians can adequately assess metabolic risk. There is little evidence that genetic differences contribute significantly to race/ethnic disparities in the endocrine disorders examined. Multilevel interventions have reduced disparities in diabetes care, and these successes can be modeled to design similar interventions for other endocrine diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2012-2043

Cites

444 of 444 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 454 references

10 of the 454 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Buchanan, 1995, The pathogenesis of GDM: implications for diabetes after pregnancy., Diabetes Rev, 3, 584
  2. Chen, 1999, HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective., J Clin Endocrinol Metab, 84, 3182
  3. Castillo-Page, 2012, Diversity in the physician workforce: facts and figures 2010

Cited by

Sorted by citations

Items 301–400 of 405

Related

See all

Metadata

Authors
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B.
Affiliations
  • Johns Hopkins University (US)
  • University of California, Los Angeles (US)
  • University of Pittsburgh (US)
  • University of Chicago (US)
  • Department of Epidemiology (T.L.G.-W.), Columbia University Mailman School of Public Health, New York, New York 10032
  • University of Michigan (US)
  • Yale University (US)
  • National Institutes of Health (US)
Corresponding author
Golden, Sherita Hill
ORCID
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2012-09-01
Volume
97
Issue
9
Pages
E1579-E1639
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jc.2012-2043
PMC
PMC3431576
OpenAlex
W2121922368
Semantic Scholar
da98249dcecbbf4ddedd56accacf919aa1ad1b28
Cited by
405
References
454
Citations by year
2026: 17 · 2025: 26 · 2024: 26 · 2023: 35 · 2022: 24 · 2021: 39 · 2020: 37 · 2019: 27 · 2018: 23 · 2017: 28 · 2016: 30 · 2015: 26 · 2014: 26 · 2013: 34 · 2012: 7
FWCI
33.87
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health (1ul1rr033176-01, UL1TR000124)
  • National Heart, Lung, and Blood Institute (P50HL105187, P50-HL0105187)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K24DK071933, P30DK079637, R01DK083297, K23DK071552, P30DK092949, P30DK092926)
  • National Center for Research Resources (UL1-RR-033176)
  • National Center for Advancing Translational Sciences
  • National Institute on Minority Health and Health Disparities
Topics
  • Social Sciences › Health › Health disparities and outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Social Sciences › Anthropology › Race, Genetics, and Society
Keywords
health disparities, endocrine disorders, racial and ethnic disparities, sex disparities, type 2 diabetes, prediabetes, diabetes complications, gestational diabetes mellitus, metabolic syndrome, obesity, dyslipidemia, thyroid dysfunction, thyroid cancer, osteoporosis, vitamin D deficiency, non-Hispanic Black population, socioeconomic status, health care access, social determinants
MeSH terms
Adult, Diabetes Mellitus, Endocrine System Diseases, Ethnicity, Female, Humans, Obesity, Osteoporosis, Prediabetic State, Pregnancy, Thyroid Diseases, United States, Vitamin D Deficiency, Diabetes, Gestational, Metabolic Syndrome, Racial Groups, Diabetes Complications, Fractures, Bone, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review